Exploring Emerging Treatments for NASH
Non-Alcoholic Steatohepatitis (NASH), also known as Metabolic Dysfunction-Associated Steatohepatitis (MASH), is a severe liver disorder linked to fat accumulation and inflammation. Research highlights a lack of FDA-approved treatments, spotlighting ongoing development and promising therapies. Lifestyle interventions remain vital in managing progression, while innovative approaches and future diagnostic and treatment strategies offer hope for affected individuals. […]